CD248 and its cytoplasmic domain: A therapeutic target for arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|62|12|3595-3606

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3595-3606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD248: Reviewing its Role in Health and Disease

By  

Current Drug Targets, Vol. 13, Iss. 3, 2012-01 ,pp. : 432-439

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleo-Cytoplasmic Transport of Proteins as a Target for Therapeutic Drugs

By  

Current Medicinal Chemistry, Vol. 10, Iss. 9, 2003-05 ,pp. : 741-748

Bentham Science Publishers

Access to resources Recommend Favorite

IL-33: a promising therapeutic target for rheumatoid arthritis?

By Yuan Feng-Lai   Li Xia   Lu Wei-Guo   Li Cheng-Wan   Xu Rui-Sheng   Dong Jian  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 529-534

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology

By  

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2631-2644

Bentham Science Publishers

Access to resources Recommend Favorite

Visfatin: a Potential Therapeutic Target for Rheumatoid Arthritis

By Bao JP   Chen WP   Wu LD  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1655-1661

Field House Publishing

Access to resources Recommend Favorite